ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Tom King To Leave NCI For Kennedy Ethics Institute; Cal Baldwin To Take NIH Job

June 27, 1980

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Obituary: Ben Horowitz, 96, Led City of Hope For 32 Years

October 8, 2010

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989